Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

365 ARTÍCULOS , VIENDO DEL 91 AL 105

The Mechanisms of Action of Curcumin in Alzheimer's Disease

Tang M, Taghibiglou C.

J Alzheimers Dis. 2017;58(4):1003-1016. doi: 10.3233/JAD-170188.

Pharmacological treatment of Alzheimer's disease in the population of Catalonia, Spain

Obach M, Lopez P, Catalan A.

Med Clin (Barc). 2017 Jul 21;149(2):86-87. doi: 10.1016/j.medcli.2017.03.030. Epub 2017 May 17.

Luteolin as a potential preventive and therapeutic candidate for Alzheimer's disease

Kwon Y.

Exp Gerontol. 2017 Sep;95:39-43. doi: 10.1016/j.exger.2017.05.014. Epub 2017 May 17.

Simvastatin ameliorate memory deficits and inflammation in clinical and mouse model of Alzheimer's disease via modulating the expression of miR-106b

Huang W, Li Z, Zhao L, Zhao W.

Biomed Pharmacother. 2017 Aug;92:46-57. doi: 10.1016/j.biopha.2017.05.060. Epub 2017 May 18.

Multi-functional activities of citrus flavonoid narirutin in Alzheimer's disease therapeutics: An integrated screening approach and in vitro validation

Chakraborty S, Basu S.

Int J Biol Macromol. 2017 Oct;103:733-743. doi: 10.1016/j.ijbiomac.2017.05.110. Epub 2017 May 19.

Amylin and its G-protein-coupled receptor: A probable pathological process and drug target for Alzheimer's disease

Qiu WQ.

Neuroscience. 2017 Jul 25;356:44-51. doi: 10.1016/j.neuroscience.2017.05.024. Epub 2017 May 19.

[Evaluation of the animal-assisted therapy in Alzheimer's disease]

Quibel C, Bonin M, Bonnet M, Gaimard M, Mourey F, Moesch I, Ancet P.

Soins Gerontol. 2017 May-Jun;22(125):35-38. doi: 10.1016/j.sger.2017.03.008.

Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease

Agrawal M, Ajazuddin, Tripathi DK, Saraf S, Saraf S, Antimisiaris SG, Mourtas S, Hammarlund-Udenaes M, Alexander A.

J Control Release. 2017 Aug 28;260:61-77. doi: 10.1016/j.jconrel.2017.05.019. Epub 2017 May 24.

Targeting Free Radicals in Oxidative Stress-Related Human Diseases

Poprac P, Jomova K, Simunkova M, Kollar V, Rhodes CJ, Valko M.

Trends Pharmacol Sci. 2017 Jul;38(7):592-607. doi: 10.1016/j.tips.2017.04.005. Epub 2017 May 24.

Biosensors for Screening Kinase Inhibitors

Bhalla N, Estrela P.

Curr Top Med Chem. 2017;17(22):2470-2481. doi: 10.2174/1568026617666170531113233.

The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models

Amit T, Bar-Am O, Mechlovich D, Kupershmidt L, Youdim MBH, Weinreb O.

Neuropharmacology. 2017 Sep 1;123:359-367. doi: 10.1016/j.neuropharm.2017.05.026. Epub 2017 May 29.

[Cataract surgery among 50 Alzheimer's patient (55 eyes)]

Girard B, Chouard B, Hardy F.

J Fr Ophtalmol. 2017 Jun;40(6):487-498. doi: 10.1016/j.jfo.2017.01.006. Epub 2017 May 29.

Cognitive training in Alzheimer's disease: a controlled randomized study

Giovagnoli AR, Manfredi V, Parente A, Schifano L, Oliveri S, Avanzini G.

Neurol Sci. 2017 Aug;38(8):1485-1493. doi: 10.1007/s10072-017-3003-9. Epub 2017 Jun 2.

Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease

Shoaib M, Kamal MA, Rizvi SMD.

Curr Drug Metab. 2017;18(9):842-852. doi: 10.2174/1389200218666170607101622.

Oxidative Stress, Mitochondrial Abnormalities and Proteins Deposition: Multitarget Approaches in Alzheimer's Disease

Nesi G, Sestito S, Digiacomo M, Rapposelli S.

Curr Top Med Chem. 2017;17(27):3062-3079. doi: 10.2174/1568026617666170607114232.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias